ETrade Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$4.12M Sell
75,189
-12,187
-14% -$668K 0.08% 132
2020
Q2
$4.62M Buy
87,376
+43,253
+98% +$2.29M 0.1% 106
2020
Q1
$1.97M Sell
44,123
-6,926
-14% -$309K 0.05% 196
2019
Q4
$2.55M Buy
51,049
+3,138
+7% +$156K 0.06% 186
2019
Q3
$2.14M Buy
47,911
+154
+0.3% +$6.86K 0.05% 207
2019
Q2
$1.97M Sell
47,757
-24,417
-34% -$1.01M 0.05% 212
2019
Q1
$2.92M Sell
72,174
-31,218
-30% -$1.26M 0.08% 140
2018
Q4
$3.93M Sell
103,392
-11,866
-10% -$451K 0.13% 85
2018
Q3
$4.56M Buy
115,258
+13,944
+14% +$552K 0.13% 88
2018
Q2
$3.56M Sell
101,314
-8,968
-8% -$315K 0.11% 104
2018
Q1
$3.86M Sell
110,282
-8,901
-7% -$311K 0.12% 88
2017
Q4
$4.14M Buy
119,183
+3,110
+3% +$108K 0.13% 86
2017
Q3
$3.93M Buy
116,073
+30,435
+36% +$1.03M 0.14% 79
2017
Q2
$2.92M Buy
85,638
+65
+0.1% +$2.22K 0.11% 98
2017
Q1
$2.67M Buy
85,573
+29,887
+54% +$931K 0.11% 108
2016
Q4
$1.52M Sell
55,686
-11,255
-17% -$307K 0.07% 162
2016
Q3
$2.2M Buy
66,941
+45,820
+217% +$1.51M 0.11% 120
2016
Q2
$638K Buy
21,121
+7,662
+57% +$231K 0.03% 297
2016
Q1
$379K Buy
13,459
+5,196
+63% +$146K 0.02% 352
2015
Q4
$281K Buy
+8,263
New +$281K 0.02% 387
2014
Q2
Sell
-4,966
Closed -$161K 451
2014
Q1
$161K Sell
4,966
-18
-0.4% -$584 0.01% 350
2013
Q4
$148K Sell
4,984
-1,312
-21% -$39K 0.01% 317
2013
Q3
$163K Buy
6,296
+2,296
+57% +$59.4K 0.02% 282
2013
Q2
$95K Buy
+4,000
New +$95K 0.01% 321